QGEN (Qiagen NV) Other Financing : $-125 Mil (TTM As of Dec. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Other Financing?

Qiagen NV's Other Financing for the three months ended in Dec. 2024 was $13 Mil.

Qiagen NV's Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 was $-125 Mil.

Qiagen NV Other Financing Historical Data

The historical data trend for Qiagen NV's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Other Financing Chart

Qiagen NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Financing

Get a 7-Day Free Trial

41.76

-16.95

-17.37

2.77

-315.57

Qiagen NV Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Financing	Get a 7-Day Free Trial															-	-	164.72	-302.90	13.17

Qiagen NV Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-125 Mil.

Qiagen NV Other Financing Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QGE3:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).

Executives